ロード中...
Cytopenia among CML Patients on Imatinib in Kenya: Types, Grades, and Time Course
BACKGROUND: Imatinib mesylate is the gold standard for the treatment of all phases of Philadelphia-positive chronic myeloid leukemia. Patients on imatinib treatment may develop cytopenia due to drug toxicity. This study aimed to determine the types, grades, and time course of cytopenia in CML patien...
保存先:
| 出版年: | Adv Hematol |
|---|---|
| 主要な著者: | , , , , , , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Hindawi
2020
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7240645/ https://ncbi.nlm.nih.gov/pubmed/32454829 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1155/2020/7696204 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|